Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STK38 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STK38 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK38 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STK38 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Stk38 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of STK38 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of STK38 mRNA | CTD | PMID:20823114 | 17beta-estradiol | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of STK38 mRNA | CTD | PMID:31614463 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STK38 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STK38 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Stk38 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of STK38 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of STK38 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of STK38 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of STK38 mRNA | CTD | PMID:30851411 | 2-methylcholine | affects expression | ISO | STK38 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of STK38 mRNA | CTD | PMID:21179406 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of STK38 mRNA | CTD | PMID:28628672 | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of STK38 mRNA | CTD | PMID:19162173 | 4,4'-diaminodiphenylmethane | affects expression | ISO | Stk38 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane affects the expression of STK38 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK38 mRNA | CTD | PMID:36041667 | 5-azacytidine | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Azacitidine results in decreased expression of STK38 mRNA | CTD | PMID:20823114 | 5-fluorouracil | affects response to substance | ISO | STK38 (Homo sapiens) | 6480464 | STK38 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 | aflatoxin B1 | decreases methylation | ISO | STK38 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of STK38 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of STK38 mRNA | CTD | PMID:33167477 | aristolochic acid A | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of STK38 protein | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | ISO | STK38 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of STK38 promoter | CTD | PMID:27901495 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK38 mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of STK38 mRNA | CTD | PMID:26496021 and PMID:36041667 | bisphenol A | decreases expression | ISO | Stk38 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of STK38 mRNA | CTD | PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of STK38 mRNA | CTD | PMID:25181051 | bisphenol F | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of STK38 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK38 mRNA | CTD | PMID:36041667 | bucladesine | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of STK38 mRNA | CTD | PMID:20823114 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of STK38 promoter | CTD | PMID:22457795 | carbon nanotube | decreases expression | ISO | Stk38 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of STK38 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to STK38 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Stk38 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of STK38 mRNA | CTD | PMID:37019170 | copper(II) sulfate | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of STK38 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of STK38 mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of STK38 mRNA | CTD | PMID:23914054 | dexamethasone | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of STK38 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Stk38 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of STK38 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of STK38 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | EXP | | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of STK38 mRNA | CTD | PMID:17347304 | ethanol | affects expression | ISO | Stk38 (Mus musculus) | 6480464 | Ethanol affects the expression of STK38 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK38 mRNA | CTD | PMID:22206623 | FR900359 | increases phosphorylation | ISO | STK38 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of STK38 protein | CTD | PMID:37730182 | fulvestrant | increases methylation | ISO | STK38 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of STK38 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of STK38 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of STK38 mRNA | CTD | PMID:33387578 | hydralazine | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of STK38 mRNA | CTD | PMID:17183730 | indometacin | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of STK38 mRNA | CTD | PMID:28628672 | irinotecan | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Irinotecan metabolite results in increased expression of STK38 mRNA and Irinotecan results in increased expression of STK38 mRNA | CTD | PMID:15956246 | iron dichloride | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of STK38 mRNA | CTD | PMID:35984750 | lead(0) | affects expression | ISO | STK38 (Homo sapiens) | 6480464 | Lead affects the expression of STK38 mRNA | CTD | PMID:28903495 | leflunomide | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of STK38 mRNA | CTD | PMID:28988120 | medroxyprogesterone acetate | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of STK38 mRNA | CTD | PMID:20823114 | methotrexate | affects expression | ISO | Stk38 (Mus musculus) | 6480464 | Methotrexate affects the expression of STK38 mRNA | CTD | PMID:18502557 | methylmercury chloride | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of STK38 mRNA | CTD | PMID:28001369 | nickel atom | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Nickel results in decreased expression of STK38 mRNA | CTD | PMID:23195993 | paracetamol | affects expression | ISO | Stk38 (Mus musculus) | 6480464 | Acetaminophen affects the expression of STK38 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of STK38 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of STK38 mRNA | CTD | PMID:21420995 | paracetamol | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of STK38 mRNA | CTD | PMID:22230336 | PCB138 | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Stk38 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of STK38 mRNA | CTD | PMID:36331819 | potassium chromate | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of STK38 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STK38 mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of STK38 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of STK38 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of STK38 mRNA | CTD | PMID:25895662 | sodium arsenate | increases expression | ISO | Stk38 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of STK38 mRNA | CTD | PMID:21795629 | sodium arsenate | decreases expression | ISO | Stk38 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of STK38 mRNA | CTD | PMID:21795629 | sodium arsenite | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of STK38 mRNA | CTD | PMID:34032870 | temozolomide | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of STK38 mRNA | CTD | PMID:31758290 | testosterone | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Testosterone] results in increased expression of STK38 mRNA | CTD | PMID:26496021 | testosterone enanthate | affects expression | ISO | STK38 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of STK38 mRNA | CTD | PMID:17440010 | urethane | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Urethane results in increased expression of STK38 mRNA | CTD | PMID:28818685 | valproic acid | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of STK38 mRNA more ... | CTD | PMID:17183730 and PMID:27188386 | valproic acid | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of STK38 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | STK38 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of STK38 mRNA | CTD | PMID:25979313 | vanadium atom | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Vanadium results in increased expression of STK38 mRNA | CTD | PMID:19000753 | vanadium(0) | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Vanadium results in increased expression of STK38 mRNA | CTD | PMID:19000753 | vitamin E | increases expression | ISO | STK38 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of STK38 mRNA | CTD | PMID:19244175 | vorinostat | decreases expression | ISO | STK38 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of STK38 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | ISO | STK38 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK38 mRNA | CTD | PMID:27188386 | |